304 related articles for article (PubMed ID: 25924689)
1. Clinical characteristics of concomitant nephrotic IgA nephropathy and minimal change disease in children.
Shen H; Gu W; Mao J; Zhu X; Jin X; Fu H; Liu A; Shu Q; Du L
Nephron; 2015; 130(1):21-8. PubMed ID: 25924689
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
Qin J; Yang Q; Tang X; Chen W; Li Z; Mao H; Jiang Z; Huang F; Yu X
Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116
[TBL] [Abstract][Full Text] [Related]
3. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH
Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
5. IgA nephropathy with minimal change disease.
Herlitz LC; Bomback AS; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Clin J Am Soc Nephrol; 2014 Jun; 9(6):1033-9. PubMed ID: 24721885
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals].
; Jiang XY
Zhonghua Er Ke Za Zhi; 2007 Apr; 45(4):272-8. PubMed ID: 17706064
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy.
Han SH; Kang EW; Park JK; Kie JH; Han DS; Kang SW
Nephrol Dial Transplant; 2011 May; 26(5):1570-5. PubMed ID: 20841490
[TBL] [Abstract][Full Text] [Related]
8. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
9. Does electron microscopy change the view of the diagnosis of IgA nephropathy?
Maixnerová D; Honsová E; Merta M; Reiterová J; Rysavá R; Tesar V; Obeidová H; Motan J
Prague Med Rep; 2005; 106(3):283-90. PubMed ID: 16463586
[TBL] [Abstract][Full Text] [Related]
10. Mild mesangial proliferative IgA nephropathy with and without minimal change disease.
Wang S; Huang B; Wang P; Liu Y; Liu Y; Chen H; Zhang J
Clin Exp Med; 2023 Dec; 23(8):5367-5376. PubMed ID: 37796359
[TBL] [Abstract][Full Text] [Related]
11. Glomerulonephritis Histopathological Pattern Change.
AlYousef A; AlSahow A; AlHelal B; Alqallaf A; Abdallah E; Abdellatif M; Nawar H; Elmahalawy R
BMC Nephrol; 2020 May; 21(1):186. PubMed ID: 32423387
[TBL] [Abstract][Full Text] [Related]
12. [Multicenter investigation of therapeutic status of children with IgA nephropathy in China].
Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):486-90. PubMed ID: 24267127
[TBL] [Abstract][Full Text] [Related]
13. Pathological patterns of primary nephrotic syndrome in Central China: a retrospective study of 627 cases.
Chu F; Chen G; Liu Y
Ren Fail; 2014 May; 36(4):514-9. PubMed ID: 24564431
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
15. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
16. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
Ozdamar SO; Gucer S; Tinaztepe K
Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features, diagnosis, and treatment of IgA nephropathy with minimal change disease related to exposure to mercury-containing cosmetics: a case report
.
Niu HX; Li SH; Li HY; Chen YH; Liu WW; Li PL; Long HB
Clin Nephrol; 2017 Apr; 87 (2017)(4):196-201. PubMed ID: 28102816
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study.
Wang J; Juan C; Huang Q; Zeng C; Liu Z
Nephrol Dial Transplant; 2013 Sep; 28(9):2339-45. PubMed ID: 23787555
[TBL] [Abstract][Full Text] [Related]
20. Key pathological features characterize minimal change disease-like IgA nephropathy.
Wang TY; Chang FP; Yang AH; Ka SM; Chen A; Hsieh JT; Chen FY; Lee TL; Tseng PY; Tsai MT; Li SY; Yang CY; Chen JY; Lin CC; Tarng DC
PLoS One; 2023; 18(7):e0288384. PubMed ID: 37471324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
